Figure 8.
Number of patients with at least one hospitalization prior to PP3M start and during PP3M treatment (mITT population).
Only patients with both baseline and at least one post-baseline assessment were included in the analysis.
LOCF, last observation carried forward; mITT, modified intent-to-treat; PP3M, paliperidone palmitate 3-month formulation; SR, symptomatic remission.